Skip to content
Physician-backed infrastructure for aesthetic & wellness practicesSupport 9 AM–5 PM EST ·(888) 996-6173 ·info@medgrid.com
MedGrid
FDA Daily

FDA daily for Friday, October 2, 2026

192 FDA records across 4 sections. 1 touches MedGrid's categories and is listed first.

192FDA Records
4 of 7Sections With Data
1Touch MedGrid Categories

Sections in This Issue

Drug shortagesCovers FDA's Thu, Oct 1 (yesterday)
136
  • Clonazepam Tablet

    Clonazepam, Tablet, 1 mg (NDC 0093-3212-05) — Teva Pharmaceuticals USA, Inc.

    Reverified · Current · Neurology

  • Sterile Water Irrigant

    Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-03) — Otsuka ICU Medical LLC

    Reverified · Current · Gastroenterology

  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0527-0763-37) — Lannett Company, Inc.

    Reverified · Current · Psychiatry

  • Methylphenidate Hydrochloride Tablet, Extended Release

    Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30) — Vertical Pharmaceuticals, LLC

    Reverified · Current · Psychiatry

  • Atropine Sulfate Injection

    Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25) — American Regent, Inc.

    Reverified · Current · Anesthesia

  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

    Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01) — Teva Pharmaceuticals USA, Inc.

    Reverified · Current · Psychiatry

  • Methylphenidate Hydrochloride Tablet, Extended Release

    Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01) — Teva Pharmaceuticals USA, Inc.

    Revised · Current · Psychiatry

  • Hydroxocobalamin Injection

    Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11) — BTG International Inc.

    Reverified · Current · Other

  • Dextrose Monohydrate 5% Injection

    Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-37) — Otsuka ICU Medical LLC

    Reverified · Current · Endocrinology/Metabolism

  • Sodium Bicarbonate Injection

    Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4) — Exela Pharma Sciences, LLC

    Reverified · Current · Endocrinology/Metabolism

  • Dextrose Monohydrate 10% Injection

    Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03) — Otsuka ICU Medical LLC

    Reverified · Current · Endocrinology/Metabolism

  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet

    Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0527-1502-37) — Lannett Company, Inc.

    Reverified · Current · Psychiatry

Showing 12 of 136. Search the rest in openFDA.

Drug approvalsCovers FDA's Fri, Sep 25 (a week ago)
33
  • ROSUVASTATIN CALCIUM

    ROSUVASTATIN CALCIUM — BIOCON PHARMA

    ANDA207752 · Labeling

  • KETOROLAC TROMETHAMINE

    KETOROLAC TROMETHAMINE — ADAPTIS

    ANDA221041 · Original approval

  • LAMLIQUE

    LAMOTRIGINE HEMIFUMARATE — AZURITY

    NDA221109 · Original approval

  • ATEBRIOZ

    ZILURGISERTIB FUMARATE — MIRUM

    NDA221198 · Original approval

  • ACYCLOVIR

    ACYCLOVIR — CADILA

    ANDA204313 · Labeling

  • DEGEVMA

    DENOSUMAB-ADET — TEVA PHARMACEUTICALS, INC.

    BLA761481 · Original approval

  • LOSARTAN POTASSIUM

    LOSARTAN POTASSIUM — WATSON LABS

    ANDA091129 · Labeling

  • METRONIDAZOLE

    METRONIDAZOLE — AUROBINDO PHARMA LTD

    ANDA218485 · Original approval

  • ROSUVASTATIN CALCIUM

    ROSUVASTATIN CALCIUM — SANDOZ

    ANDA079171 · Labeling

  • GOBARDEN

    BENDAMUSTINE HYDROCHLORIDE — AVYXA HOLDINGS

    NDA219014 · Labeling

  • GAZYVA

    OBINUTUZUMAB — GENENTECH

    BLA125486 · Efficacy

  • THIAMINE HYDROCHLORIDE

    THIAMINE HYDROCHLORIDE — HONG KONG

    ANDA213131 · Original approval

Showing 12 of 33. Search the rest in openFDA.

Drug recallsCovers FDA's Fri, Sep 25 (a week ago)
Nothing from FDA for this date
Food and supplement recallsCovers FDA's Fri, Sep 25 (a week ago)
Nothing from FDA for this date
Device recallsCovers FDA's Fri, Sep 25 (a week ago)
Nothing from FDA for this date
Device clearancesCovers FDA's Fri, Sep 18 (two weeks ago)
1 touch MedGrid19
  • Dental Diode Laser Device (Laser-Pen)Touches MedGrid categories

    Guilin Kevin Peter Technology Co., Ltd.

    K261047 · Substantially Equivalent · General, Plastic Surgery

  • Drainage Catheter

    Canyon Medical, Inc.

    K254179 · Substantially Equivalent · Gastroenterology, Urology

  • Mesh Nebulizer (UN204); Mesh Nebulizer (UN205); Mesh Nebulizer (UN209); Mesh Nebulizer (UN210)

    Shenzhen Mericonn Technology Co., Ltd.

    K254171 · Substantially Equivalent · Anesthesiology

  • SLIT LAMP SL-D4 (Type: LED)

    Topcon Corporation

    K262637 · Substantially Equivalent · Ophthalmic

  • 25G Huber Needle

    Martech Medical Products

    K254095 · Substantially Equivalent · General Hospital

  • NORMOFLO™ Irrigation Fluid Warming Sets and Accessories (IR-601, IR-501, IR-61, PL-61)

    ICU Medical

    K262532 · Substantially Equivalent · General Hospital

  • SCENARIA View Phase 6.0

    Fujifilm Corporation

    K261229 · Substantially Equivalent · Radiology

  • VacHeal Negative Pressure Wound Therapy System

    VacHeal, LLC

    K254160 · Substantially Equivalent · General, Plastic Surgery

  • MINT MONO Sutures

    Hans Biomed Corporation

    K254238 · Substantially Equivalent · General, Plastic Surgery

  • CrossFAST Integrated Microcatheter Advanced Delivery System

    Vantis Vascular, Inc.

    K262817 · Substantially Equivalent · Cardiovascular

  • UNIDRIVE Select System

    Karl Storz SE & CO. KG

    K261102 · Substantially Equivalent · Obstetrics/Gynecology

  • Pathfinder Endoscope Overtube

    Neptune Medical, Inc.

    K262262 · Substantially Equivalent · Gastroenterology, Urology

Showing 12 of 19. Search the rest in openFDA.

Label changesCovers FDA's Fri, Sep 18 (two weeks ago)
4
  • venlafaxine hydrochloride, extended release

    Edenbridge Pharmaceuticals LLC.

    Label version 5

  • Propofol

    Civica, Inc

    Label version 8

  • Drug label

    Label version 8

  • Drug label

    Label version 2

How the FDA Daily Is WrittenSources, dates and what gets flagged

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug recalls, device recalls and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Items that touch the categories MedGrid works in, such as GLP-1s, hormones, injectables, peptides, compounded products and aesthetic devices, are marked and listed first.

Subscribe with any feed reader, or point an email tool at theRSS feed. For the rules behind the headlines, see Regulations Research.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.